Oculis Holding AG (OCS) Consolidated Net Income (2022 - 2026)

Oculis Holding AG's (OCS) quarterly Consolidated Net Income came in at -$37.1 million in Q1 2026, little changed year-on-year from -$37.3 million in Q1 2025, and down 151.01% quarter-over-quarter from $72.7 million in Q4 2025.

Oculis Holding AG (OCS) Consolidated Net Income (2022 - 2026) Analysis & Trends

Oculis Holding AG's Consolidated Net Income history runs 5 years deep, the most recent figure standing at -$37.1 million for Q1 2026.

  • On a quarterly basis, Consolidated Net Income changed 0.46% year-over-year to -$37.1 million in Q1 2026; TTM through Mar 2026 was -$21.0 billion, a 9.94% increase from a year earlier, with the FY2025 full-year figure at -$119.8 million, down 22.42% from the prior year.
  • Consolidated Net Income declined to -$37.1 million in Q1 2026 per OCS's latest filing, from $72.7 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $72.7 million in Q4 2025 and bottomed at -$23.3 billion in Q3 2024.
  • The 5-year median for Consolidated Net Income is -$21.4 million (2024), against an average of -$2.8 billion.
  • Across the five-year window, Consolidated Net Income tumbled 117115.04% in 2024 and jumped 318.67% in 2025, its largest moves.
  • Year by year, Consolidated Net Income stood at -$9.6 million in 2022, then slumped by 47.68% to -$14.1 million in 2023, then tumbled by 135.51% to -$33.3 million in 2024, then soared by 318.67% to $72.7 million in 2025, then slumped by 151.01% to -$37.1 million in 2026.
  • Per Business Quant, the three latest OCS Consolidated Net Income figures stand at -$37.1 million (Q1 2026), $72.7 million (Q4 2025), and -$21.0 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -37.09 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -14.46 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 227.36 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 727.20 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -26.94 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 498.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -453.82 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 205.99 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -37.09 Mn
Dec 31, 2025 72.72 Mn
Sep 30, 2025 -21.04 Bn
Jun 30, 2025 -30.71 Mn
Mar 31, 2025 -36.93 Mn
Dec 31, 2024 -33.25 Mn
Sep 30, 2024 -23.26 Bn
Jun 30, 2024 -22.98 Mn
Mar 31, 2024 -18.37 Mn
Dec 31, 2023 -14.12 Mn
Sep 30, 2023 -19.85 Mn
Jun 30, 2023 -14.07 Mn
Mar 31, 2023 -49.48 Mn
Dec 31, 2022 -9.56 Mn
Sep 30, 2022 -10.29 Mn
Jun 30, 2022 -12.73 Mn